| Dr Kristie Lynn Keeton, MD | |
|
4918 W Clark Rd Ste 104, Ypsilanti, MI 48197-1142 | |
| (734) 528-9125 | |
| (734) 528-9263 |
| Full Name | Dr Kristie Lynn Keeton |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 4918 W Clark Rd Ste 104, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295855070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 4301074290 (Michigan) | Primary |
| 207V00000X | Obstetrics & Gynecology | 4301074290 (Michigan) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
News Archive
Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).
Researchers from the Swedish Defense Research Agency (FOI) and Umeå University wanted to improve the treatment of nerve agent poisoning.
Orthodontics is the vehicle that delivers a patient's teeth to their final destination of a stunning, straight smile. That vehicle must be correctly maintained and cared for if it is going to arrive at its destination in a timely manner, and without costly repairs and setbacks.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
› Verified 6 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).
Researchers from the Swedish Defense Research Agency (FOI) and Umeå University wanted to improve the treatment of nerve agent poisoning.
Orthodontics is the vehicle that delivers a patient's teeth to their final destination of a stunning, straight smile. That vehicle must be correctly maintained and cared for if it is going to arrive at its destination in a timely manner, and without costly repairs and setbacks.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristie Lynn Keeton, MD 24 Frank Lloyd Wright Dr, Po Box 0446 Lobby J, Ann Arbor, MI 48105-9484 Ph: (734) 747-6766 | Dr Kristie Lynn Keeton, MD 4918 W Clark Rd Ste 104, Ypsilanti, MI 48197-1142 Ph: (734) 528-9125 |
News Archive
Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).
Researchers from the Swedish Defense Research Agency (FOI) and Umeå University wanted to improve the treatment of nerve agent poisoning.
Orthodontics is the vehicle that delivers a patient's teeth to their final destination of a stunning, straight smile. That vehicle must be correctly maintained and cared for if it is going to arrive at its destination in a timely manner, and without costly repairs and setbacks.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
› Verified 6 days ago
Katharine Micallef, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr Rm 2110, Ypsilanti, MI 48197 Phone: 734-712-3967 Fax: 734-712-2341 | |
Sharon O'leary, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4936 W Clark Rd, Building D, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-6200 Fax: 734-434-7373 | |
Dr. Tamara Pelish, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4940 W Clark Rd, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-0477 Fax: 734-434-6240 | |
Dr. Lisa Rene Jeffries, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 2110, Ypsilanti, MI 48197 Phone: 734-712-3967 | |
Dr. Allison Kreske, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 W Clark Rd, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-0477 Fax: 734-434-6240 | |
Dr. Mikel Llanes, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Arnet St, Suite 200, Ypsilanti, MI 48198 Phone: 734-482-6221 | |
Dr. Gina Long, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 W Clark Rd, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-0477 Fax: 734-434-6240 |